Novo Nordisk said 80% of U.S. patients with insurance coverage who take its highly popular weight loss treatment Wegovy are paying less than $25 a month for the drug.
The remarks suggest that many insured Americans don't have to shoulder the full cost of a monthly package of Wegovy, which has aof around $1,350. It also comes as many U.S. health insurers balk at the extreme cost of Wegovy and other obesity drugs while dropping them from their plans, even as demand for those treatments soar nationwide and outpace supply.
He estimated that about 50 million Americans with obesity could be eligible for Wegovy coverage under their health plans. Wegovy, for example, leads to 15% weight loss after 68 weeks, according to clinical trials on the drug.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: